Lifestyle behavior and the risk of type 2 diabetes in the Seguimiento Universidad de Navarra (SUN) cohort.


Journal

Nutrition, metabolism, and cardiovascular diseases : NMCD
ISSN: 1590-3729
Titre abrégé: Nutr Metab Cardiovasc Dis
Pays: Netherlands
ID NLM: 9111474

Informations de publication

Date de publication:
24 07 2020
Historique:
received: 06 08 2019
revised: 07 04 2020
accepted: 08 04 2020
pubmed: 18 6 2020
medline: 11 11 2020
entrez: 18 6 2020
Statut: ppublish

Résumé

We prospectively assessed the association between a healthy lifestyle score (HLS) and the risk of type 2 diabetes mellitus (T2DM) in a Mediterranean cohort. We followed up 11,005 participants initially free of diabetes diagnosis in the "Seguimiento Universidad de Navarra" (SUN) cohort. We evaluated the influence of lifestyle-related factors based on a score previously related to a lower risk of cardiovascular disease. Only one incident case of T2DM was found among those with a baseline BMI ≤22 kg/m Higher adherence to a HLS, including some factors not typically studied, may reduce T2DM risk. Preventive efforts should preferentially focus on weight control. However, this score may promote a comprehensive approach to diabetes prevention beyond weight reduction.

Sections du résumé

BACKGROUND AND AIMS
We prospectively assessed the association between a healthy lifestyle score (HLS) and the risk of type 2 diabetes mellitus (T2DM) in a Mediterranean cohort.
METHODS AND RESULTS
We followed up 11,005 participants initially free of diabetes diagnosis in the "Seguimiento Universidad de Navarra" (SUN) cohort. We evaluated the influence of lifestyle-related factors based on a score previously related to a lower risk of cardiovascular disease. Only one incident case of T2DM was found among those with a baseline BMI ≤22 kg/m
CONCLUSIONS
Higher adherence to a HLS, including some factors not typically studied, may reduce T2DM risk. Preventive efforts should preferentially focus on weight control. However, this score may promote a comprehensive approach to diabetes prevention beyond weight reduction.

Identifiants

pubmed: 32546389
pii: S0939-4753(20)30127-7
doi: 10.1016/j.numecd.2020.04.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1355-1364

Informations de copyright

Copyright © 2020 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Auteurs

Liz Ruiz-Estigarribia (L)

University of Navarra, Department of Preventive Medicine and Public Health, School of Medicine, Pamplona, Spain.

Miguel A Martínez-González (MA)

University of Navarra, Department of Preventive Medicine and Public Health, School of Medicine, Pamplona, Spain; CIBER Pathophysiology of Obesity and Nutrition (CIBERNobn), Institute of Health Carlos III, Madrid, Spain; IDISNA Navarra's Health Research Institute, Pamplona, Spain; Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, United States.

Jesús Díaz-Gutiérrez (J)

University of Navarra, Department of Preventive Medicine and Public Health, School of Medicine, Pamplona, Spain.

Carmen Sayón-Orea (C)

University of Navarra, Department of Preventive Medicine and Public Health, School of Medicine, Pamplona, Spain; IDISNA Navarra's Health Research Institute, Pamplona, Spain; Navarra Public Health Institute, Pamplona, Spain.

Francisco J Basterra-Gortari (FJ)

University of Navarra, Department of Preventive Medicine and Public Health, School of Medicine, Pamplona, Spain; IDISNA Navarra's Health Research Institute, Pamplona, Spain; Department of Internal Medicine (Endocrinology), Hospital Reina Sofia, Tudela, Spain.

Maira Bes-Rastrollo (M)

University of Navarra, Department of Preventive Medicine and Public Health, School of Medicine, Pamplona, Spain; CIBER Pathophysiology of Obesity and Nutrition (CIBERNobn), Institute of Health Carlos III, Madrid, Spain; IDISNA Navarra's Health Research Institute, Pamplona, Spain. Electronic address: mbes@unav.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH